<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34509927</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5967</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><PubDate><Year>2021</Year><Month>10</Month></PubDate></JournalIssue><Title>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</Title><ISOAbbreviation>J Clin Virol</ISOAbbreviation></Journal><ArticleTitle>Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants.</ArticleTitle><Pagination><MedlinePgn>104969</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1386-6532(21)00236-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcv.2021.104969</ELocationID><Abstract><AbstractText Label="BACKGROUND">The recent emergence of new SARS CoV-2 variants (variants of concern, VOC) that spread rapidly and may lead to immune escape has emphasized the urgent need to monitor and control their spread.</AbstractText><AbstractText Label="METHODS">We analyzed 2018 SARS-CoV-2 positive specimens collected between February 9 and March 22, 2021 using the Thermofisher® TaqPath™ COVID-19 CE-IVD RT-PCR kit (TaqPath) and the ID solutions® ID™ SARS-CoV-2/UK/SA Variant Triplex RT-PCR (ID triplex) assay to screen for VOCs.</AbstractText><AbstractText Label="RESULTS">The ID triplex assay identified 62.8% of them as VOCs: 61.8% B.1.1.7 and 0.9% B.1.351/P.1. The agreement between the ID triplex results for B.1.1.7 and the TaqPath S gene target failure (SGTF)/ S gene target late detection (SGTL) profile for this variant agreed very well (k = 0.86). A low virus load was the main cause of discrepancies. Sequencing discordant results with both assays indicated that the TaqPath assay detected the B.1.1.7 lineage slightly better. Both assays suggested that the virus loads of B.1.1.7 variants were significantly higher than those of non-B.1.1.7 strains. Only 10/20 B1.351/P.1 strains detected with the ID triplex assay were confirmed by sequencing.</AbstractText><AbstractText Label="CONCLUSIONS">We conclude that the SGTF/SGTL profiles identified using the TaqPath assay and ID triplex results are suitable for detecting the B.1.1.7 lineage. The ID triplex assay, which rapidly determines all three current VOCs simultaneously, could be a valuable tool for limiting virus spread by supporting contact-tracing and isolation.</AbstractText><CopyrightInformation>Copyright © 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Migueres</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse 31300, France; Université Toulouse III Paul-Sabatier, Toulouse, France. Electronic address: migueres.m@chu-toulouse.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lhomme</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse 31300, France; Université Toulouse III Paul-Sabatier, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trémeaux</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimeglio</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranger</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latour</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicot</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miedouge</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansuy</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izopet</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051, Toulouse 31300, France; Université Toulouse III Paul-Sabatier, Toulouse, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Virol</MedlineTA><NlmUniqueID>9815671</NlmUniqueID><ISSNLinking>1386-6532</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Genome sequencing</Keyword><Keyword MajorTopicYN="Y">ID triplex</Keyword><Keyword MajorTopicYN="Y">RT-PCR</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword><Keyword MajorTopicYN="Y">TaqPath</Keyword><Keyword MajorTopicYN="Y">Variants of concern (VOC)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>06</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>12</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34509927</ArticleId><ArticleId IdType="pii">S1386-6532(21)00236-5</ArticleId><ArticleId IdType="doi">10.1016/j.jcv.2021.104969</ArticleId><ArticleId IdType="pmc">PMC8411575</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>